Bristol-Myers To Pay $499M To Settle Pricing Charges
Bristol-Myers Squibb Co. has agreed in principle to pay $499 million to settle long-running government investigations into the drug maker's pricing formulas and sales and marketing activities, the company said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article